Works matching IS 17597706 AND DT 2022 AND VI 13 AND IP 10


Results: 15
    1
    2
    3
    4

    Impact of losing adipose tissue on outcomes from PD‐1/PD‐L1 inhibitor monotherapy in non‐small cell lung cancer.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 10, p. 1496, doi. 10.1111/1759-7714.14421
    By:
    • Nishioka, Naoya;
    • Naito, Tateaki;
    • Miyawaki, Taichi;
    • Yabe, Michitoshi;
    • Doshita, Kosei;
    • Kodama, Hiroaki;
    • Miyawaki, Eriko;
    • Iida, Yuko;
    • Mamesaya, Nobuaki;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Ko, Ryo;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Murakami, Haruyasu;
    • Takayama, Koichi;
    • Takahashi, Toshiaki
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02).

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 10, p. 1471, doi. 10.1111/1759-7714.14415
    By:
    • Tanaka, Hisashi;
    • Sakamoto, Hiroaki;
    • Akita, Takahiro;
    • Ohyanagi, Fumiyoshi;
    • Kawashima, Yosuke;
    • Tambo, Yuichi;
    • Tanimoto, Azusa;
    • Horiike, Atsushi;
    • Miyauchi, Eisaku;
    • Tsuchiya‐Kawano, Yuko;
    • Yanagitani, Noriko;
    • Nishio, Makoto
    Publication type:
    Article
    14
    15

    Issue Information.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 10, p. 1439, doi. 10.1111/1759-7714.14024
    Publication type:
    Article